Cargando…
The Long-Term Survival of a Patient With Stage IV Renal Cell Carcinoma Following an Integrative Treatment Approach Including the Intravenous α-Lipoic Acid/Low-Dose Naltrexone Protocol
In this case report, we describe the treatment of a 64-year-old male patient diagnosed with metastatic renal cell carcinoma (RCC) in June of 2008. In spite of a left nephrectomy and the standard oncological protocols, the patient developed a solitary left lung metastasis that continued to grow. He w...
Autores principales: | Berkson, Burton M., Calvo Riera, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142095/ https://www.ncbi.nlm.nih.gov/pubmed/29258346 http://dx.doi.org/10.1177/1534735417747984 |
Ejemplares similares
-
Adverse Effects of High Doses of Intravenous Alpha Lipoic Acid on Liver Mitochondria
por: Vigil, Michael, et al.
Publicado: (2014) -
Effect of α-Lipoic Acid on Oxidative Stress in End-Stage Renal Disease Patients Receiving Intravenous Iron
por: Showkat, Arif, et al.
Publicado: (2014) -
Low-Dose Naltrexone in Rheumatological Diseases
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2023) -
Low-Dose Naltrexone for Pruritus in Systemic Sclerosis
por: Frech, Tracy, et al.
Publicado: (2011) -
Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012)